$7.5B in emergency congressional coronavirus prep; Sickle cell biotech sets terms for IPO
→ Multiple outlets, including the Washington Post, are reporting that Congress is preparing to approve a $7.5 billion emergency coronavirus …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
